These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1696325)

  • 21. Hematopoietic growth factors in bone marrow transplantation for hematologic malignancies.
    Lazarus HM
    Prog Clin Biol Res; 1990; 352():531-8. PubMed ID: 1698303
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defense.
    Gutterman J; Vadhan-Raj S; Logothetis C; Anaissle E; Estey E; Talpaz M; Kurzrock R
    Semin Hematol; 1990 Jul; 27(3 Suppl 3):15-24. PubMed ID: 2198660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical use of hematopoietic growth factors.
    Appelbaum FR
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow failure and hematopoietic growth factors.
    Douer D
    Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor.
    Greenberg P; Negrin R; Nagler A; Souza L; Donlon T
    Prog Clin Biol Res; 1990; 338():151-61. PubMed ID: 1693211
    [No Abstract]   [Full Text] [Related]  

  • 27. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
    Hast R; Bernell P
    Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term disappearance of previous chromosomal abnormalities in myelodysplastic syndromes treated with low dose cytosine arabinoside and granulocyte/macrophage-colony stimulating factor.
    Sastre JL; Ulibarrena C; Bustillo M; Suárez-Gago M; García-Torremocha MS; Vázquez MO
    Haematologica; 1998 Aug; 83(8):763-5. PubMed ID: 9793271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase-I/II trial.
    Ganser A; Völkers B; Greher J; Walther F; Hoelzer D
    Onkologie; 1988 Feb; 11(1):53-5. PubMed ID: 3283627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemopoietic growth factors: a review.
    Morstyn G; Burgess AW
    Cancer Res; 1988 Oct; 48(20):5624-37. PubMed ID: 2458827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.
    Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642
    [No Abstract]   [Full Text] [Related]  

  • 32. Target cells for GM-CSF and kinetics of response.
    Aglietta M; Bussolino F; Piacibello W; Aprá F; Sanavio F; Stacchini A; Monzeglio C; Carnino F; Stern AC; Gavosto F
    Prog Clin Biol Res; 1990; 352():519-30. PubMed ID: 2169636
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
    Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
    Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
    [No Abstract]   [Full Text] [Related]  

  • 34. Myelodysplastic syndromes: a review for nurses.
    Cain J; Hood-Barnes J; Spangler J
    Oncol Nurs Forum; 1991; 18(1):113-7. PubMed ID: 2003103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationals for the development of the human hematopoietic colony stimulating factors as therapeutical useful drugs.
    Krumwieh D; Schulz G; Seiler FR
    Behring Inst Mitt; 1988 Apr; (82):265-81. PubMed ID: 2457362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The myelodysplastic syndromes: biology and implications for management.
    List AF; Garewal HS; Sandberg AA
    J Clin Oncol; 1990 Aug; 8(8):1424-41. PubMed ID: 1696311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic growth factors in the treatment of patients with HIV infection.
    Mitsuyasu RT
    Biotherapy; 1990; 2(2):173-81. PubMed ID: 1698092
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
    Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
    [No Abstract]   [Full Text] [Related]  

  • 39. [Medical application of genetics].
    Takaku F
    Jpn J Genet; 1989 Oct; 64(5):391-405. PubMed ID: 2483668
    [No Abstract]   [Full Text] [Related]  

  • 40. [GM-CSF: granulocyte and macrophage colony stimulating factor. A biologic agent with a great therapeutic potential in oncology].
    Cortes-Funes H
    Rev Clin Esp; 1990 Mar; 186(4):173-4. PubMed ID: 2195605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.